Sargramostim (GM-CSF)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Sargramostim (GM-CSF), covering 2008-03-04 to 2018-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia [Phase 2]